erlotinib hydrochloride has been researched along with Multiple Hemangioblastomas in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaelin, W; LoRusso, P; Malik, G; Nadler, P; Rogers, LR; Shields, A | 1 |
1 other study(ies) available for erlotinib hydrochloride and Multiple Hemangioblastomas
| Article | Year |
|---|---|
Erlotinib therapy for central nervous system hemangioblastomatosis associated with von Hippel-Lindau disease: a case report.
Topics: Adult; Central Nervous System Neoplasms; Erlotinib Hydrochloride; Female; Hemangioblastoma; Humans; Protein Kinase Inhibitors; Quinazolines; Treatment Outcome; von Hippel-Lindau Disease | 2011 |